MNMD logo

Mind Medicine (MindMed) Inc. Common Shares


MNMD: Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies.


Show MNMD Financials

Consumer Interest
SEC Filings

Recent trades of MNMD by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by MNMD's directors and management

Government lobbying spending instances

  • $30,000 Jul 19, 2023 Issue: Health Issues
U.S. Patents

New patents grants

  • Patent Title: 18-mc for treatment of substance use disorders Mar. 07, 2023
  • Patent Title: System and method for patient monitoring of gastrointestinal function using automated stool classifications Dec. 20, 2022
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of MNMD in WallStreetBets Daily Discussion


Recent insights relating to MNMD

CNBC Recommendations

Recent picks made for MNMD stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MNMD

Corporate Flights

Flights by private jets registered to MNMD